Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7452 p577
19 May 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


New details of Alliance Boots private equity scheme revealed to shareholders

Further details of the planned scheme to take Alliance Boots into private ownership were laid out in a circular last week.

The proposed date for the acquisition by AB Acquisitions is 26 June, with Alliance Boots shares being delisted on 28 June. AB Acquisitions is jointly controlled by Stefano Pessina, executive deputy chairman of Alliance Boots, and the private equity firm Kohlberg Kravis Roberts.

The circular, sent out to all Alliance Boots shareholders, also revealed that, should the scheme become effective and all options be exercised in full, Mr Pessina will receive £820,539, Richard Baker, chief executive, will receive £6,543,379 and Steve Duncan, community pharmacy director, will receive £530,938.

In an introductory letter to the circular Sir Nigel Rudd, chairman of Alliance Boots, says that KKR and Mr Pessina insist that long-term growth of Alliance Boots can be best achieved under private ownership.

“KKR and Stefano Pessina believe that the rapid structural changes in the pharmacy retail and wholesale markets in Europe will require an acceleration of Alliance Boots’s transition to a pharmacy-led health and beauty and services-oriented business,” he says. AB Acquisitions intends, he adds, “to enhance Alliance Boots’s positioning as a leading provider of health care and beauty advice and services in the local community, both by increasing investment in existing stores and by expanding the store portfolio”.

AB Acquisitions has given assurances that Alliance Boots’s pension obligations will be fully complied with. However, discussions with the trustees of each of Alliance Boots’s three pension schemes are ongoing, Sir Nigel says.

Back to Top


©The Pharmaceutical Journal